• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Polypill strategy reduces the risk of cardiovascular events after a myocardial infarction

byDavid XiangandKiera Liblik
September 15, 2022
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A polypill consisting of aspirin, ramipril, and atorvastatin reduced the risk of major adverse cardiovascular events after a myocardial infarction (MI). 

2. Medication adherence was higher in patients receiving the polypill compared to usual care.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The incidence of recurrent ischemic events is increasing globally despite effective pharmacotherapies which have been developed for secondary prevention. Notably, patient adherence to secondary prevention medications is only estimated to be approximately 50%. It follows that a lack of adherence to these pharmaceuticals is associated with poor outcomes. A polypill strategy has been proposed to improve medication adherence through treatment simplification by reducing the number of medications taken. However, there is a gap in knowledge as to understanding the efficacy of a polypill-based strategy compared to usual care concerning major cardiovascular outcomes in older patients with recent myocardial infarction (MI). Overall, this study found that the polypill treatment strategy led to a lower frequency of cardiovascular events than a usual care strategy. This study was limited as no adjustment was made for multiple comparisons of secondary outcomes, and loss to follow-up may potentially bias comparisons between groups. Finally, the coronavirus disease 2019 pandemic might have precluded some patients from completing trial visits. Nevertheless, these study’s findings are significant, as they demonstrate that this polypill strategy can significantly reduce the risk of adverse cardiovascular events after a MI and can improve accessibility and adherence to treatment.

Click to read the study in NEJM

Relevant Reading: Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease

In-Depth [randomized controlled trial]: The present phase three randomized control trial was conducted at 113 centers across Europe. In this trial, patients with a MI within the previous six months were assigned to a polypill strategy or usual care. The polypill regimen consisted of aspirin, ramipril, and atorvastatin. Patients with a history of type one MI within the previous 6 months and who were older than 75 or 65 with a risk factor such as diabetes or kidney disease were eligible for the study. Patients who were receiving oral anticoagulation were excluded from the study. The primary outcome measures were cardiovascular death, nonfatal type one MI, nonfatal ischemic stroke, and urgent revascularization. Outcomes in the primary analysis were assessed via noninferiority according to the intention to treat principle with Kaplan-Meier analyses and log-rank tests. Based on the primary analysis, a primary outcome event occurred in 9.5% of patients in the polypill group and in 12.7% of patients in the usual care control group (Hazard Ratio [HR] 0.76; 95% Confidence Interval [CI] 0.6 to 0.96). A key secondary outcome event occurred in 8.2% of the polypill group and in 11.7% of the usual care group (HR 0.7; 95% CI 0.54 to 0.9). Medication adherence at six months as reported by patients was higher in the polypill group at 70.6% compared to 62.7% in the usual care group (Risk Ratio 1.13; 95% CI 1.06 to 1.2). In summary, this study demonstrates that a polypill treatment strategy significantly reduces the risk of major cardiovascular adverse events after a MI in older patients and significantly improves adherence to these key medications.

RELATED REPORTS

Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia

Chronic obstructive pulmonary disease associated with worse postoperative outcomes

Empagliflozin use is associated with slower progression of chronic kidney disease

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute coronary syndromeacute myocardial infarctionaspirinAtorvastatincardiologycardiovascular eventschronic diseasemyocardial infarctionpharmacologypolypillramipril
Previous Post

Human papillomavirus infection is associated with adenocarcinoma of the cervix [Classics Series]

Next Post

Wellness Check: Sleep

RelatedReports

Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia

January 27, 2023
2 Minute Medicine Rewind May 20, 2019
Chronic Disease

Chronic obstructive pulmonary disease associated with worse postoperative outcomes

January 26, 2023
Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Empagliflozin use is associated with slower progression of chronic kidney disease

January 26, 2023
#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma
StudyGraphics

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

January 24, 2023
Next Post
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Wellness Check: Sleep

Patient transfers to trauma centers often unnecessary

Enteral glutamine does not reduce the time to discharge for severe burns

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

Intraperitoneal chemotherapy improves advanced ovarian cancer survival [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options